GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNUM.L Regulatory News (NUM)

  • There is currently no data for NUM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

3 Apr 2023 07:00

RNS Number : 0335V
Numis Corporation PLC
03 April 2023
 

Numis Corporation Plc

Trading Update

3 April 2023

 

Numis Corporation Plc (Numis), the independent investment banking group, today issues a trading update in respect of the six-month period ended 31 March 2023.

 

Key highlights:

 

· Our diversified business model continues to deliver a resilient performance through the market cycle with revenue for first half of FY23 expected to be in the region of £64m, approximately 14% below the comparative period, despite weaker overall investment banking markets.

· The outlook for M&A remains encouraging, with a record first half for advisory.

· Continued scarcity of UK ECM transactions across the market has resulted in lower investment banking revenues.

· Following a good start to the year, equities revenues will be lower than the comparative period, due to both institutional income and trading businesses experiencing a weaker end to the half year.

· Our balance sheet remains strong with both liquidity and capital positions enabling the capacity to deliver shareholder returns and continued investment in our strategy to deliver growth through the market cycle.

 

 

Summary review

 

Investment banking

 

In the first half we have continued to build on the successful diversification of our UK investment banking business, delivering another strong advisory performance. M&A revenues have benefited from continued momentum in securing financial adviser mandates from our corporate broking client base.

 

In line with the broader industry, capital markets revenues will be materially lower than the comparative period. Whilst our ECM market share in the UK has increased relative to FY22, overall market levels of issuance remain at historic lows. Engagement with our corporate clients remains strong and we are encouraged by the investor support achieved in recent capital raising transactions. Growth capital solutions, our private markets business, has experienced a pick up in deal activity and pipeline development, following reduced market activity levels in H2 FY22. We are well positioned to advise the most ambitious growth companies globally and remain excited by the potential for this business as activity levels recover.

 

Equities

 

We continued to build our European client base during the period, in line with the strategy to enhance our distribution capability beyond the UK and support our EU ECM marketing efforts. Investor sentiment toward the UK remains relatively weak with domestic focused institutional investors experiencing persistent fund outflows during the period. As a result, institutional income was lower than the comparative period and our trading profit was flat over the last two months of the half year as market conditions remained challenging.

 

Outlook

 

The outlook for our advisory business remains positive with a good pipeline of both buy-side and sell-side mandates, reflecting both continued activity in the UK mid-market and the strength of our corporate relationships. Our strong corporate broking franchise ensures we are well positioned to benefit from a recovery in capital markets volumes, however, we do not envisage a meaningful change in market conditions in the short term. As a consequence, we believe that it is unlikely that the IPO market will see any meaningful pick-up during the remainder of our financial year to 30 September 2023.

 

Our balance sheet remains strong with both liquidity and capital positions providing the group with capacity to deliver shareholder returns and invest in our strategy to deliver growth through the market cycle. During the first half we enhanced our product offerings across investment banking and equities, and we will continue to selectively assess growth opportunities as they emerge during this period of ongoing market uncertainty.

 

Contacts:

 

Numis:

Noreen Biddle-Shah, Head of Communications

020 7260 1441

FTI Consulting LLP:

Edward Bridges

07768 216607

Daisy Hall

07807 298568

Ambrose Fullalove

07970 982748

Grant Thornton UK LLP (Nominated Adviser):

Philip Secrett

020 7728 2578

Harrison Clarke

020 7184 4384

Ciara Donnelly

020 7728 2889

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018.

 

 

Notes for Editors

Numis (LON: NUM) is an independent, international investment bank that partners with the most ambitious companies and investors, offering strategic advice, unique insights and connectivity to the capital markets.

 

Already a leader in the UK market, Numis is the adviser of choice for listed companies, including one-fifth of the FTSE 350 index, with an average market capitalisation of £1bn, and has acted on the most UK IPOs over the past decade.

 

Since 2016, Numis has diversified its strategy to grow its UK M&A franchise, expand internationally and develop its private markets business, which combined now account for almost half of investment banking revenues.

 

Numis is listed on London's AIM and has offices in London, New York and Dublin.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUASBRORUOOAR
Date   Source Headline
30th Mar 20217:00 amRNSTrading Update
9th Feb 20215:48 pmRNSResult of AGM
9th Feb 20217:00 amRNSAGM Trading Update
2nd Feb 20215:02 pmRNSTransfer of Shares from Treasury to EBT and TVR
22nd Jan 20217:00 amRNSDirector Dealing
19th Jan 20217:00 amRNSGrant of awards under 2021 LTIP
5th Jan 20219:00 amRNSAnnual Report and Annual General Meeting Notice
4th Jan 20212:36 pmRNSTR-1: Notification of major holdings
16th Dec 20205:00 pmRNSDirectors’ Dealing
11th Dec 20203:00 pmRNSTR-1: Notification of major holdings
10th Dec 20203:45 pmRNSTR-1: Notification of major holdings
10th Dec 202010:17 amRNSTransfer of Shares from Treasury to EBT and TVR
8th Dec 20207:00 amRNSPreliminary Results for the year ended 30 Sep 2020
3rd Dec 20204:55 pmRNSTransaction in Own Shares and Total Voting Rights
1st Dec 20203:31 pmRNSTransaction in Own Shares and Total Voting Rights
1st Dec 20209:02 amRNSNotice of Preliminary Results for year end 30 Sep
25th Nov 20203:50 pmRNSTransaction in Own Shares and Total Voting Rights
23rd Nov 20203:50 pmRNSTransaction in Own Shares and Total Voting Rights
19th Nov 20204:27 pmRNSTransaction in Own Shares and Total Voting Rights
18th Nov 20204:32 pmRNSTransaction in Own Shares and Total Voting Rights
11th Nov 20204:22 pmRNSTransaction in Own Shares and Total Voting Rights
9th Nov 20205:51 pmRNSTransaction in Own Shares and Total Voting Rights
5th Nov 20205:36 pmRNSTransaction in Own Shares and Total Voting Rights
15th Oct 20205:10 pmRNSTransaction in Own Shares and Total Voting Rights
8th Oct 20206:24 pmRNSTR-1: Notification of major holdings
7th Oct 20202:25 pmRNSTransaction in Own Shares and Total Voting Rights
6th Oct 20208:48 amRNSForm 8.5 (EPT/RI) - RWS Holdings plc
30th Sep 20207:00 amRNSPurchase of Shares in Close Period
29th Sep 20204:00 pmRNSTransaction in Own Shares and Total Voting Rights
28th Sep 20204:00 pmRNSTR-1: Notification of major holdings
28th Sep 20207:00 amRNSTrading Update
23rd Sep 20205:16 pmRNSTransaction in Own Shares and Total Voting Rights
22nd Sep 20204:04 pmRNSTransaction in Own Shares and Total Voting Rights
15th Sep 202011:42 amRNSTransaction in Own Shares and Total Voting Rights
11th Sep 20209:11 amRNSTransaction in Own Shares and Total Voting Rights
27th Aug 20203:47 pmRNSTransaction in Own Shares and Total Voting Rights
25th Aug 20205:45 pmRNSTransaction in Own Shares and Total Voting Rights
12th Aug 20204:15 pmRNSTransaction in Own Shares and Total Voting Rights
31st Jul 20209:37 amRNSTransaction in Own Shares and Total Voting Rights
16th Jul 20203:11 pmRNSTransaction in Own Shares and Total Voting Rights
3rd Jul 20207:00 amRNSQ3 Trading Update
2nd Jul 20204:52 pmRNSTransaction in Own Shares and Total Voting Rights
30th Jun 20203:42 pmRNSTransaction in Own Shares and Total Voting Rights
29th Jun 20209:48 amRNSTransaction in Own Shares and Total Voting Rights
23rd Jun 202010:46 amRNSTransaction in Own Shares and Total Voting Rights
18th Jun 202010:24 amRNSTransaction in Own Shares and Total Voting Rights
15th Jun 20203:47 pmRNSTransaction in Own Shares and Total Voting Rights
12th Jun 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Jun 202010:49 amRNSTransaction in Own Shares and Total Voting Rights
8th Jun 20205:17 pmRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.